Patents by Inventor Wilhelmus Gerardus Johannes Degen

Wilhelmus Gerardus Johannes Degen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240041760
    Abstract: The invention pertains to a vaccine comprising non-live antigen of a poultry pathogen and a mucoadhesive adjuvant, for use in boosting an immune response in a poultry animal directed against the poultry pathogen by administering the vaccine mucosally to the poultry animal. The invention also pertains to a vaccine comprising a liquid pharmaceutically acceptable carrier, a non-live antigen of a poultry pathogen and a mucoadhesive adjuvant, as well as a method of boosting an immune response in a poultry animal, which immune response is directed against a poultry pathogen, by administering a vaccine mucosally to the poultry animal, the vaccine comprising a non-live antigen of the said poultry pathogen and a mucoadhesive adjuvant.
    Type: Application
    Filed: February 7, 2021
    Publication date: February 8, 2024
    Applicant: Intervet Inc.
    Inventors: Willem Pieter Cornelis Pulskens, Paul Vermeij, Theodorus Jansen, Wilhelmus Gerardus Johannes Degen, Carla Christina Schrier
  • Patent number: 9757449
    Abstract: The addition of an oligodeoxynucleotide that is an avian TLR21 agonist, to an avian Herpesvirus vector vaccine, provides an acceleration of the immune response against the antigen that is expressed and delivered by the Herpesvirus vector.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: September 12, 2017
    Assignee: Intervet Inc.
    Inventors: Carla Christina Schrier, Wilhelmus Gerardus Johannes Degen
  • Publication number: 20160158347
    Abstract: The addition of an oligodeoxynucleotide that is an avian TLR21 agonist, to an avian Herpesvirus vector vaccine, provides an acceleration of the immune response against the antigen that is expressed and delivered by the Herpesvirus vector.
    Type: Application
    Filed: July 25, 2014
    Publication date: June 9, 2016
    Applicant: Intervet Inc.
    Inventors: Carla Christina Schrier, Wilhelmus Gerardus Johannes Degen
  • Publication number: 20110110887
    Abstract: The present invention pertains to the use of a recombinant Herpesvirus of Turkeys (HVT) containing a heterologous nucleic acid sequence that encodesinter-leukin-12, to manufacture a medicament which protects a bird against Marek's disease virus and reduces its sensitivity for microbial infection.
    Type: Application
    Filed: June 22, 2009
    Publication date: May 12, 2011
    Inventors: Wilhelmus Gerardus Johannes Degen, Virgil Elisaeth Joseph Caspar Schijns
  • Publication number: 20110027222
    Abstract: The present invention pertains to a vaccine for the treatment of osteoarthritis in a vertebrate comprising IL-1? and optionally TNF-? cytokines or derivatives thereof, and in association with said IL-1? and optional TNF-? or derivatives thereof a part that is non-self with respect to the vertebrate such that the vaccine elicits an immune response in the vertebrate against IL-1? and TNF-? self-molecules of the said vertebrate.
    Type: Application
    Filed: September 24, 2008
    Publication date: February 3, 2011
    Inventors: Wilhelmus Gerardus Johannes Degen, Virgil Elisabeth Joseph Caspar Schijns
  • Patent number: 7347996
    Abstract: Embodiments of the present invention generally relate to novel avian cytokines, to DNA sequences encoding these novel cytokines and to their use in adjuvants for vaccine purposes.
    Type: Grant
    Filed: June 17, 2003
    Date of Patent: March 25, 2008
    Assignees: Intevert International B.V., UD Technology Corporation
    Inventors: Wilhelmus Gerardus Johannes Degen, Virgil Elisabeth Joseph Caspar Schijns
  • Publication number: 20080063623
    Abstract: Embodiments of the present invention generally relate to novel avian cytokines, to DNA sequences encoding these novel cytokines and to their use in adjuvants for vaccine purposes.
    Type: Application
    Filed: June 17, 2003
    Publication date: March 13, 2008
    Inventors: Wilhelmus Gerardus Johannes Degen, Virgil Elisabeth Joseph C Schijns